Fintel reports that on October 25, 2024, Maxim Group initiated coverage of reAlpha Tech (NasdaqCM:AIRE) with a Buy ...

Fintel reports that on October 25, 2024, Maxim Group upgraded their outlook for Annovis Bio (NYSE:ANVS) from Hold to Buy. ...

Maxim Group has recently initiated Assertio Holdings Inc (ASRT) stock to Buy rating, as announced on July 26, 2024, according to Finviz. Earlier, on July 3, 2024, H.C. Wainwright had initiated the ...

Maxim Group analyst Michael Diana maintained a Hold rating on Westamerica Bancorporation (WABC – Research Report) yesterday. The ...

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, today announced that Brian M.

Bionomics Limited (Nasdaq: BNOX) (Bionomics or Company), a clinical-stage biotechnology company developing novel, ...

Applied DNA Sciences, Inc. (NASDAQ:APDN) (”Applied DNA”), a leader in PCR-based DNA technologies, today announced that Dr. James A. Hayward, president and chief executive officer, will participate in ...

Maxim Group initiated coverage on GameSquare Holdings Inc (NASDAQ: NASDAQ:GAME) with a Buy rating and a price target of $3.00. The firm cited the company's compelling valuation as a key reason for ...

Tuesday, Maxim (NASDAQ:MXIM) Group began coverage on shares of Ocugen, Inc. (NASDAQ: NASDAQ:OCGN), issuing a Buy rating and setting a price target of $4.00. The firm highlighted Ocugen's financial ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Maxim (NASDAQ:MXIM) Group initiated coverage on GameSquare Holdings Inc (NASDAQ: NASDAQ:GAME) with a Buy rating and a price target of $3.00. The firm cited the company's compelling valuation as a key ...